Ozempic could save taxpayers trillions if weight-loss drug gains in popularity

Published



Healthcare spending is eating up an increasingly large portion of the federal budget, to the point that over the next 30 years, per the nonpartisan Congressional Budget Office, healthcare outlays will consume $1 out of every $10 of our annual total economic output.

Thankfully, private-sector scientific innovation may help tamp down the healthcare red ink, specifically semaglutide, better known as Ozempic. Approved in 2017 by the Food and Drug Administration for use in adults with Type 2 diabetes, Ozempic has taken the world by storm for its unparalleled success as an anti-obesity measure. Even television viewers unfamiliar with the drug have likely heard its commercial jingle, “Oh, Oh, Oh, Ozempic,” a riff on David Paton’s 1974 song “Magic,” which reached No. 5 in the United States on the Billboard Hot 100.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.